Top Market Performers: Iovance, SoundThinking, and WidePoint Lead Stock Gains

• Iovance Biotherapeutics (NASDAQ: IOVA) surged after raising its 2026 revenue guidance, supported by strong demand for Amtagvi.
• SoundThinking, Inc. (NASDAQ: SSTI) jumped after agreeing to be acquired by Transom Capital Group.
• WidePoint Corporation (NYSE American: WYY) gained after an update tied to a major Department of Homeland Security contract decision.

Today’s stock market gains were driven by company-specific catalysts. Iovance Biotherapeutics (NASDAQ: IOVA)rose 31.48% to $14.45 after increasing its 2026 revenue outlook. The biotechnology company cited strong demand for Amtagvi, its cancer immunotherapy product, as a key growth driver, as reported by Barron’s.

SoundThinking, Inc. (NASDAQ: SSTI) climbed 50.09% to $8.21 after Transom Capital Group agreed to take the company private. The deal includes $8.00 per share in cash, plus potential additional value through contingent rights, according to The Wall Street Journal.

WidePoint Corporation (NYSE American: WYY) rose 24.58% to $7.35 after issuing an update related to the Department of Homeland Security’s Cellular Wireless Managed Services 3.0 contract award.

Other gainers included Armada Acquisition Corp. II (NASDAQ: XRPN), which rose 21.99% to $12.90, and Leverage Shares 2x Long BE Daily ETF (LSE: BEG), which gained 20.65% to $55.60.

Overall, the day’s strongest moves were tied to revenue guidance, acquisition activity, and government contract developments.